Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002

被引:96
作者
Flamm, RK [1 ]
Weaver, MK [1 ]
Thornsberry, C [1 ]
Jones, ME [1 ]
Karlowsky, JA [1 ]
Sahm, DF [1 ]
机构
[1] Focus Technol, Herndon, VA 20171 USA
关键词
D O I
10.1128/AAC.48.7.2431-2436.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
For the period from 1999 to 2002 in the United States, the in vitro susceptibilities of 52,637 Pseudomonas aeruginosa isolates to 10 antimicrobial agents were evaluated. The isolates were from 29 laboratories, 11 of which participated in The Surveillance Network for four consecutive years. Isolates were collected from adult patients (2:18 years of age) in intensive care units (ICU), non-ICU inpatients, nursing home patients, and outpatients; data were analyzed to evaluate factors, such as year of isolation, patient age group, isolate specimen source, and patient type (hospitalized patients [ICU, non-ICU, or nursing home] or outpatients). Rates of resistance for the 4-year period were highest for isolates from patients in ICU and 18- to 39-year-old patients and for isolates from the lower respiratory tract. Resistance decreased with age. Resistance was lowest in isolates from outpatients, in isolates from greater than or equal to70-year-old patients, and from specimens from the upper respiratory tract. Multidrug resistance (MDR) (resistance to three or more antimicrobial agents) accounted for 24.9% of all isolates. The MDR rate was highest in isolates from patients in nursing homes (29.9%) and ICU (29.5%).
引用
收藏
页码:2431 / 2436
页数:6
相关论文
共 17 条
[1]  
[Anonymous], M100S12 NAT COMM CLI
[2]  
[Anonymous], [No title captured]
[3]   Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa [J].
Carmeli, Y ;
Troillet, N ;
Karchmer, AW ;
Samore, MH .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (10) :1127-1132
[4]  
Diekema DJ, 1999, CLIN INFECT DIS, V29, P595, DOI 10.1086/598640
[5]   Mortality due to ventilator-associated pneumonia or colonization with Pseudomonas or Acinetobacter species: Assessment by quantitative culture of samples obtained by a protected specimen brush [J].
Fagon, JY ;
Chastre, J ;
Domart, Y ;
Trouillet, JL ;
Gibert, C .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (03) :538-542
[6]   Characterization of Pseudomonas aeruginosa isolates:: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999 [J].
Gales, AC ;
Jones, RN ;
Turnidge, J ;
Rennie, R ;
Ramphal, R .
CLINICAL INFECTIOUS DISEASES, 2001, 32 :S146-S155
[7]   Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa [J].
Harris, A ;
Torres-Viera, C ;
Venkataraman, L ;
DeGirolami, P ;
Samore, M ;
Carmeli, Y .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) :1128-1133
[8]   Geographic variations in activity of broad-spectrum β-lactams against Pseudomonas aeruginosa:: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000) [J].
Jones, RN ;
Kirby, JT ;
Beach, ML ;
Biedenbach, DJ ;
Pfaller, MA .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 43 (03) :239-243
[9]   Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States [J].
Karlowsky, JA ;
Kelly, LJ ;
Thornsberry, C ;
Jones, ME ;
Evangelista, AT ;
Critchley, IA ;
Sahm, DF .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 19 (01) :21-31
[10]   Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii [J].
Levin, AS ;
Barone, AA ;
Penço, J ;
Santos, MV ;
Marinho, IS ;
Arruda, EAG ;
Manrique, EI ;
Costa, SF .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (05) :1008-1011